Dysplastic nevus epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Dysplastic nevus}} ==References== {{refli...") |
Aditya Ganti (talk | contribs) |
||
(6 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Dysplastic nevus}} | {{Dysplastic nevus}} | ||
{{CMG}} | |||
==Overview== | |||
Dysplatstic nevi are very commonly seen in white people. The prevalence of any atypical nevi in white-skinned populations ranges from 2 to 10 percent. Acquired dysplastic nevi are more common in childhood and adolescence and reach a maximum number in early adulthood. | |||
== Epidemiology and Demographics == | |||
=== Incidence === | |||
* The prevalence of any atypical nevi in white-skinned populations ranges from 2 to 10 percent.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref> | |||
* Some of the prevalence variation is explained by differences in the diagnostic criteria used. | |||
* In patients with a personal history of melanoma, the estimated prevalence is 30 to 60 percent. | |||
=== Age === | |||
* Acquired dysplastic nevi are more common in childhood and adolescence and reach a maximum number in early adulthood.<ref name="SEER" /> | |||
=== Race === | |||
* Melanocytic nevi are reported to be less common in Asian and black people.<ref name="SEER" /> | |||
=== Gender === | |||
* Males are more commonly affected by dysplastic nevus compared to females. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Line 9: | Line 30: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Types of cancer]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Dermatology]] | |||
[[Category:Surgery]] |
Latest revision as of 05:06, 4 June 2019
Dysplastic nevus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Dysplastic nevus epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Dysplastic nevus epidemiology and demographics |
Risk calculators and risk factors for Dysplastic nevus epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Dysplatstic nevi are very commonly seen in white people. The prevalence of any atypical nevi in white-skinned populations ranges from 2 to 10 percent. Acquired dysplastic nevi are more common in childhood and adolescence and reach a maximum number in early adulthood.
Epidemiology and Demographics
Incidence
- The prevalence of any atypical nevi in white-skinned populations ranges from 2 to 10 percent.[1]
- Some of the prevalence variation is explained by differences in the diagnostic criteria used.
- In patients with a personal history of melanoma, the estimated prevalence is 30 to 60 percent.
Age
- Acquired dysplastic nevi are more common in childhood and adolescence and reach a maximum number in early adulthood.[1]
Race
- Melanocytic nevi are reported to be less common in Asian and black people.[1]
Gender
- Males are more commonly affected by dysplastic nevus compared to females.
References
- ↑ 1.0 1.1 1.2 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.